MedPath

Study held to see the effect of Mansyadi Kwath Shirodhara and Jala-Dhara in the management of Chittodvega (Generalized Anxiety Disorder)

Phase 2
Conditions
Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders
Registration Number
CTRI/2022/04/041845
Lead Sponsor
Dr Vaishali R Chaudhari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Anxiety, Restlessness, Being Easily Fatigue, Difficulty In Concentration, Irritability, Muscle tension, Insomnia

Exclusion Criteria

Drug Abuse, Panic Disorder, Social Phobia, Obsessive Compulsive Disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare the effectiveness of Mansyadi Kwath Shirodhara and Jala-Dhara in management of Chittodvega with special reference to Generalized Anxiety Disorder.Timepoint: on 1st day and last day i.e. 21t day of completion of treatment.
Secondary Outcome Measures
NameTimeMethod
Effectiveness of Mansyadi Kwath Shirodhara in the management of Chittodvega(Generalized Anxiety Disorder)Timepoint: 1st day and last day i.e. 21st day of completion of treatment.
© Copyright 2025. All Rights Reserved by MedPath